319 related articles for article (PubMed ID: 36012109)
1. Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy.
Shefer A; Yalovaya A; Tamkovich S
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012109
[TBL] [Abstract][Full Text] [Related]
2. Exosomal Cargo in Ovarian Cancer Dissemination.
Dzhugashvili E; Tamkovich S
Curr Issues Mol Biol; 2023 Dec; 45(12):9851-9867. PubMed ID: 38132461
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability.
Baldasici O; Pileczki V; Cruceriu D; Gavrilas LI; Tudoran O; Balacescu L; Vlase L; Balacescu O
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012638
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Derived Exosomes Mediate the Instability of Cadherins and Promote Tumor Progression.
Wang B; Tan Z; Guan F
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357383
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells.
Yin X; Zheng X; Liu M; Wang D; Sun H; Qiu Y; Chen J; Shi B
Cell Biol Int; 2020 Apr; 44(4):958-965. PubMed ID: 31872468
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.
Donnarumma E; Fiore D; Nappa M; Roscigno G; Adamo A; Iaboni M; Russo V; Affinito A; Puoti I; Quintavalle C; Rienzo A; Piscuoglio S; Thomas R; Condorelli G
Oncotarget; 2017 Mar; 8(12):19592-19608. PubMed ID: 28121625
[TBL] [Abstract][Full Text] [Related]
11. Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
Huang CS; Ho JY; Chiang JH; Yu CP; Yu DS
Cells; 2020 Jun; 9(6):. PubMed ID: 32517366
[TBL] [Abstract][Full Text] [Related]
12. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.
Han B; Zhang H; Tian R; Liu H; Wang Z; Wang Z; Tian J; Cui Y; Ren S; Zuo X; Tian R; Niu R; Zhang F
Theranostics; 2022; 12(9):4127-4146. PubMed ID: 35673569
[No Abstract] [Full Text] [Related]
13. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
[TBL] [Abstract][Full Text] [Related]
14. Exosomes and exosomal RNAs in breast cancer: A status update.
Lakshmi S; Hughes TA; Priya S
Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870
[TBL] [Abstract][Full Text] [Related]
15. Exosome: emerging biomarker in breast cancer.
Jia Y; Chen Y; Wang Q; Jayasinghe U; Luo X; Wei Q; Wang J; Xiong H; Chen C; Xu B; Hu W; Wang L; Zhao W; Zhou J
Oncotarget; 2017 Jun; 8(25):41717-41733. PubMed ID: 28402944
[TBL] [Abstract][Full Text] [Related]
16. Exosome cargo reflects TGF-β1-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cells.
Kim J; Kim TY; Lee MS; Mun JY; Ihm C; Kim SA
Biochem Biophys Res Commun; 2016 Sep; 478(2):643-8. PubMed ID: 27492069
[TBL] [Abstract][Full Text] [Related]
17. miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
Coon J; Kingsley K; Howard KM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727045
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function.
Pelissier Vatter FA; Lucotti S; Zhang H
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):305-317. PubMed ID: 33351162
[TBL] [Abstract][Full Text] [Related]
19. Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy.
Hu C; Jiang W; Lv M; Fan S; Lu Y; Wu Q; Pi J
Front Immunol; 2022; 13():792046. PubMed ID: 35757760
[TBL] [Abstract][Full Text] [Related]
20. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
